Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000879169-25-000004
Filing Date
2025-01-03
Accepted
2025-01-03 13:06:45
Documents
1
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1735927599.html 4  
1 FORM 4 wk-form4_1735927599.xml 4 3554
  Complete submission text file 0000879169-25-000004.txt   5302
Mailing Address 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803
Business Address 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803 3024986700
INCYTE CORP (Issuer) CIK: 0000879169 (see all company filings)

EIN.: 943136539 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O BIOGEN IDEC INC. 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142
Business Address
Clancy Paul J (Reporting) CIK: 0001409601 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12400 | Film No.: 25504998